A Population Health Approach to Managing Heart Failure

A panel of medical experts open a discussion surrounding heart failure and its prevalence in health care.

Jim Januzzi, MD, outlines a multitude of drug treatment options for heart failure revolving around patient ejection fraction (EF) status.

Ryan Haumschild, PharmD, MS, MBA, leads a conversation regarding value statements and their alignment with cost-effective care.

Panelists discuss treatment for heart failure in the presence of comorbid disease impacting payer considerations.

Drs Uppal and Januzzi explore benefits of population health programs for treating chronic conditions associated with heart failure.

Dr Haumschild leads an overview of updates to ACC guidelines directing treatment of patients with heart failure.

Dr Januzzi analyzes preventive approaches for patients with pre-heart failure, including comorbidity considerations and preliminary testing.

Medical experts discuss benefits of titrating therapies for management of ejection fraction pathologies.

Rohit Uppal, MD, MBA, SFH, outlines unique treatment strategies for various ejection fraction types in the presence of comorbidities.

Jaime Murillo, MD, shares insight on the significance of early use of American College of Cardiology treatment guidelines to manage total cost of care for patients with heart failure.

The panel explores clinical evaluations, such as the PROVE-HF study and PARADIGM-HF trial.

Experts discuss improving outcomes for patients with heart failure through appropriate and timely switches to ARN inhibitors.

Jaime Murillo, MD, outlines payer utilization management strategies identified by the PARADIGM-HF study.

The impact of SGLT2 inhibitors in heart failure treatment is highlighted by the EMPEROR-Preserved and EMPEROR-Reduced trials.

Dr Murillo navigates cost-saving strategies for heart failure treatment by emphasizing collaborative care between specialists and frontline primacy care teams.

Dr Uppal outlines population health management strategies directed to improve access to care and treatment management for patients with heart failure.

Multiple comorbidities lead to an emphasis on multidisciplinary care management when determining the most effective HF treatment strategies.

Experts share their thoughts on payer and provider perceptions surrounding affordable HF care, as well as strategies to manage care-associated costs.

The panel of experts provide their final insights regarding unmet needs surrounding treatment management of heart failure.